Association of State-Imposed Restrictions on Gabapentin with Changes in Prescribing in Medicare.
Jordan S GrauerJohn D CramerPublished in: Journal of general internal medicine (2022)
Classifying gabapentin as a Schedule V drug results in substantial reduction in total days prescribed whereas PDMP regulation results in modest reduction.